Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
Titel:
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
Auteur:
Zhou, Caicun Kim, Sang-We Reungwetwattana, Thanyanan Zhou, Jianying Zhang, Yiping He, Jianxing Yang, Jin-Ji Cheng, Ying Lee, Se-Hoon Bu, Lilian Xu, Tingting Yang, Li Wang, Chao Liu, Ting Morcos, Peter N Lu, You Zhang, Li